Press Releases
Imago BioSciences Reports Second Quarter 2021 Financial Results and Provides Recent Business Updates
Aug 19, 2021
Imago BioSciences Receives Orphan Designation From European Medicines Agency for Bomedemstat for the Treatment of Essential Thrombocythemia
Jul 30, 2021
Imago BioSciences, Inc. Announces Exercise of Underwriters’ Option to Purchase Additional Shares
Jul 26, 2021
Imago BioSciences, Inc. Announces Closing of $134.4 Million Initial Public Offering
Jul 20, 2021
Imago BioSciences, Inc. Announces Pricing of Upsized Initial Public Offering of Common Stock
Jul 15, 2021
Displaying 21 - 25 of 60